IM Cannabis Closes Three Strategic Acquisitions In Israel Valued Around $11.77M
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) has completed three strategic acquisitions.
Panaxia Confirms First Export Of Medical Cannabis Sublingual Tablets To France
Cannabis-focused pharma company Panaxia Labs Israel (TASE:PNAX) (OTCEM:PXLIF) and a subsidiary of Panaxia Global, together with Neuraxpharm Group announced Monday a first export of medical cannabis sublingual tablets from Israel to France.
Panaxia Q2 Revenue Grows 19.2% Reaching $5.49M, Sells Its Secondary Operations In Israel
Panaxia Labs Israel Ltd. (TASE: PNAX) (OTCPK: PXLIF) a subsidiary of Panaxia Global released its financial reports on Thursday for the second quarter and first half of 2021, revealing second-quarter revenues of NIS17.6 million ($5.49 million), up by 19.2% from NI